Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
HIV and Aging: The Potential Role of Inflammation
Normal Life Expectancy With Maintenance of CD4s Above 500
HIV Eradication: One Step Closer
Chemical in Bananas May Prevent and Treat HIV
New Hope for HIV Eradication
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

November 4, 2008

Drug-Resistant Staph: Growing Concern Among People With HIV

by Tim Horn

Skin infections caused by drug-resistant staph are more common and more likely to recur in people living with HIV, according to three new studies reported at the 2008 joint meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the Infectious Disease Society of America (IDSA) last week in Washington, DC. The new data also suggest that the number of new infections caused by methicillin-resistant Staphylococcus aureus (MRSA) has increased in recent years and that it is most likely to involve the buttocks and genital area in HIV-positive people.

The majority of MRSA infections occur in hospitals or other health care settings. A growing concern, however, is an upswing in the number of community-acquired MRSA (CA-MRSA) infections. Like hospital-acquired MRSA (HA-MRSA), CA-MRSA is more difficult to treat than typical staph infections. CA-MRSA is, however, potentially more dangerous because it contains a toxin that attacks white blood cells and can lead to serious skin and soft tissue infections and a serious form of pneumonia.

HIV infection has been said to be a risk factor for CA-MRSA, notably skin and soft tissue infections. Although CA-MRSA can be treated, certain antibiotics must be used cautiously in people living with HIV because drug interactions and allergic reactions are common. There also appears to be a higher CA-MRSA recurrence rate among HIV-positive people.

At ICAAC/IDSA, Kyle Popovich, MD, and his colleagues associated with the Cook County Healthcare and Hospital System—which includes care facilities throughout the greater Chicago area—reported that the risk of CA-MRSA skin and soft tissue infections is about six times higher among HIV-infected patients compared with HIV-uninfected patients. There were 952 cases of CA-MRSA per 100,000 HIV-positive people in the county, compared with 156 per 100,000 HIV-negative people in the county, resulting in a “relative risk” of 6.1.

In the Veterans Aging Cohort Study (VACS), involving more than 3,000 HIV-positive patients and age- and race-matched HIV-negative controls, Christopher Graber, MD, MPH, and his colleagues found a threefold higher risk of CA-MRSA in people living with HIV. Of the 2,652 HIV-positive patients included in the study, 122 (4.6 percent) required treatment for CA-MRSA between 2000 and 2007. Of the 2,728 HIV-negative patients evaluated, 43 (1.5 percent) were diagnosed with CA-MRSA at some point during this seven-year period.

Dr. Graber’s group also reported that HIV-positive patients were much more likely to have a CA-MRSA-related infection of the buttocks or genital area (notably the perineum) than HIV-negative individuals. Conversely, HIV-negative individuals were much more likely to develop skin and soft-tissue infections caused by CA-MRSA in the foot area.

Cases of CA-MRSA among HIV-positive people also appear to be on the rise. According to Dr. Popovich’s presentation, there were 373 reports of CA-MRSA among HIV-positive patients between 2000 and 2003. Between 2004 and 2007, however, there were 1,426 cases reported—a fourfold increase in the number of new CA-MRSA cases.

A second study reported by Popovich, focusing specifically on HIV-positive patients hospitalized at Stroger Hospital in Chicago, found an increase in the number of CA-MRSA among hospitalized patients (MRSA acquired before being admitted but diagnosed while in the hospital). Between 2000 and 2003, 190 HIV-positive patients admitted to Stroger had CA-MRSA skin and soft tissue infections. Between 2004 and 2007, the rate increased fourfold, to 779 hospitalized HIV-positive patients with active CA-MRSA infections.

Among the Stroger-treated patients, CA-MRSA infection was most likely to be documented in those coming from “high risk” residences, such as substance abuse centers, shelters or subsidized housing, as well as those residing in “high risk” zip codes—defined by the researchers as localities in which there are high incarceration rates.

Graber’s presentation noted that there appears to be equal susceptibility of CA-MRSA to antibiotics among HIV-positive and HIV-negative individuals. He said that TMP/SMX (Bactrim) and rifampin (Rifadin) appear to be the most effective, but that these options can be potentially problematic in people living with HIV; many HIV-positive people are allergic to Bactrim, and many are taking ARVs that must be used cautiously with Rifadin.

Graber also noted that recurrences of CA-MRSA skin and soft tissue infections are more likely to occur in HIV-positive patients. In his group’s VACS analysis, there were 21 CA-MRSA recurrences among the HIV-positive patients, compared with two recurrences among the HIV-negative patients. These findings, Graber pointed out, echo those of at least one other recent study.

For more information regarding MRSA and HIV, check out Tim Horn's video interview with Dr. Nancy Crum-Cianflone at the 2008 ICAAC/IDSA meeting in Washington, DC (click here).

Search: HIV, MRSA, , Staphyloccocus aureus, staph, Chicago, Cook County, Veterans Aging Cohort Study, prevalence, incidence, recurrence


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 5 (of 5 total)    

mike, Bradenton, FL, 2008-11-07 13:02:20
i have been dealing with a staph like infection for 3 years now, every culture(4) comes back neg, but, my HIV doc is convinced it is some form of staph, so i was put on a double dose of Bactrim which almost killed me, is it possible for a new type of staph to not culture a positive result? i have pimple like weeping sores and a necrotic wound on my right side of my neck, very painful, itchy, after 5 antibiotics this past summer, they have had no effect. i am worried.

Tim Horn, AIDSmeds.com, New York, NY, 2008-11-06 16:17:58
Johnny -- MRSA can be spread via skin-to-skin contact. This means that it can be transmitted sexually. However, it can also spread via more casual contact, thus it is not an "STI" in the traditional sense.

HawaiHuck, Honolulu, 2008-11-06 14:41:13
Are you infering, that MRSA is sexually transmitted?

Johnny808, Honolulu, 2008-11-06 14:37:54
Is the inference here that MRSA may be transmitted sexually? [Is MRSA an STD???] Since this is the site location, of the MRSA in the Ass or Genital areas?

Mnaoj Kumar, Tamil Nadu India, 2008-11-05 23:23:41
Very useful information.. Thank You.

comments 1 - 5 (of 5 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

XVIII International AIDS Conference
Vienna, Austria
July 18-23, 2010


17th Conference on Retroviruses and Opportunistic Infections (CROI 2010)
San Francisco, CA
February 16-19, 2010


5th IAS Conference on HIV Pathogenesis Treatment and Prevention (IAS 2009)
Cape Town, South Africa
July 19-22, 2009

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2010 Smart + Strong. All Rights Reserved. Terms of use and Your privacy